Cancer Treatment-induced Oral Mucositis - Anticancer Research

79 Jebb SA, Osborne RJ, Maughan TS, Mohideen N, Mack P,
Mort D, Shelley MD and Elia M: 5-fluorouracil and folinic acidinduced
mucositis: no effect of oral glutamine supplementation.
Br J Cancer 70(4): 732-735, 1994.
80 van Zaanen HC, van der Lelie H, Timmer JG, Furst P and
Sauerwein HP: Parenteral glutamine dipeptide supplementation
does not ameliorate chemotherapy-induced toxicity. Cancer
74(10): 2879-2884, 1994.
81 Okuno SH, Woodhouse CO, Loprinzi CL, Sloan JA,
LaVasseur BI, Clemens-Schutjer D, Swan D, Axvig C, Ebbert
LP, Tirona MR, Michalak JC and Pierson N: Phase III
controlled evaluation of glutamine for decreasing stomatitis in
patients receiving fluorouracil (5-FU)-based chemotherapy.
Am J Clin Oncol 22(3): 258-261, 1999.
82 Carnel SB, Blakeslee DB, Oswald SG and Barnes M:
Treatment of radiation- and chemotherapy-induced stomatitis.
Otolaryngol Head Neck Surg 102(4): 326-330, 1990.
83 Turhal NS, Erdal S and Karacay S: Efficacy of treatment to
relieve mucositis-induced discomfort. Support Care Cancer
8(1): 55-58, 2000.
84 LeVeque FG, Parzuchowski JB, Farinacci GC, Redding SW,
Rodu B, Johnson JT, Ferretti GA, Eisenberg PD and
Zimmer MB: Clinical evaluation of MGI 209, an anesthetic,
film-forming agent for relief from painful oral ulcers
associated with chemotherapy. J Clin Oncol 10(12): 1963-
1968, 1992.
85 Redding SW: Role of herpes simplex virus reactivation in
chemotherapy-induced oral mucositis. NCI Monogr 9: 103-
105, 1990.
86 Yamamura K, Ohta S, Yano K, Yotsuyanagi T, Okamura T
and Nabeshima T: Oral mucosal adhesive film containing local
anesthetics: in vitro and clinical evaluation. J Biomed Mater
Res 43(3): 313-317, 1998.
87 Epstein JB, Truelove EL, Oien H, Allison C, Le ND and
Epstein MS: Oral topical doxepin rinse: analgesic effect in
patients with oral mucosal pain due to cancer or cancer
therapy. Oral Oncol 37(8): 632-637, 2001.
88 De Souza CA, Santini G, Marino G, Nati S, Congiu AM,
Vigorito AC and Damasio E: Amifostine (WR-2721) , a
cytoprotective agent during high-dose cyclophosphamide
treatment of non-Hodgkin’s lymphomas: a phase II study. Braz
J Med Biol Res 33(7): 791-798, 2000.
89 Fahlke J, Ridwelski K and Lippert H: High-dose therapy with
combined 5-fluorouracil and folinic acid with and without
amifostine in the treatment of patients with metastatic
colorectal carcinoma. Int J Colorectal Dis 14(2): 128-130,
1999.
90 Stokman MA, Spijkervet FK, Burlage FR, Dijkstra PU,
Manson WL, de Vries EG and Roodenburg JL: Oral mucositis
and selective elimination of oral flora in head and neck cancer
patients receiving radiotherapy: a double-blind randomised
clinical trial. Br J Cancer 88(7): 1012-106, 2003.
91 Wadleigh RG, Redman RS, Graham ML, Krasnow SH,
Anderson A and Cohen MH: Vitamin E in the treatment of
chemotherapy-induced mucositis. Am J Med 92(5): 481-484,
1992.
92 Lopez I, Goudou C, Ribrag V, Sauvage C, Hazebroucq G and
Dreyfus F: Treatment of mucositis with vitamin E during
administration of neutropenic antineoplastic agents. Ann Med
Interne (Paris) 145(6): 405-408, 1994.
Alterio et al: Cancer Treatment-induced Mucositis (Review)
93 Thornley I, Lehmann LE, Sung L, Holmes C, Spear JM,
Brennan L, Vangel M, Bechard LJ, Richardson P, Duggan C
and Guinan EC: A multiagent strategy to decrease regimenrelated
toxicity in children undergoing allogeneic
hematopoietic stem cell transplantation. Biol Blood Marrow
Transplant 10(9): 635-644, 2004.
94 Clark PI and Slevin ML: Allopurinol mouthwashes and 5fluorouracil
induced oral toxicity. Eur J Surg Oncol 11(3): 267-
268, 1985.
95 Tsavaris NB, Komitsopoulou P, Tzannou I, Loucatou P,
Tsaroucha-Noutsou A, Kilafis G and Kosmidis P: Decreased
oral toxicity with the local use of allopurinol in patients who
received high dose 5-fluorouracil. Sel Cancer Ther 7(3): 113-
117, 1991.
96 Howell SB, Pfeifle CE and Wung WE: Effect of allopurinol on
the toxicity of high-dose 5-fluorouracil administered by
intermittent bolus injection. Cancer 51(2): 220-225, 1983.
97 Porta C, Moroni M and Nastasi G: Allopurinol mouthwashes
in the treatment of 5-fluorouracil-induced stomatitis. Am J
Clin Oncol 17(3): 246-247, 1994.
98 Weiss GR, Green S, Hannigan EV, Boutselis JG, Surwit EA,
Wallace DL and Alberts DS: A phase II trial of cisplatin and
5-fluorouracil with allopurinol for recurrent or metastatic
carcinoma of the uterine cervix: a Southwest Oncology Group
trial. Gynecol Oncol 37(3): 354-358, 1990.
99 Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham
NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann
LM et al: A controlled evaluation of an allopurinol mouthwash
as prophylaxis against 5-fluorouracil-induced stomatitis.
Cancer 65(8): 1879-1882, 1990.
100 Awidi A, Homsi U, Kakail RI, Mubarak A, Hassan A, Kelta
M, Martinez P, Sulaiti S, Al Qady A, Jamhoury A, Daniel M,
Charles C, Ambrose A and El-Aloosy AS: Double-blind,
placebo-controlled cross-over study of oral pilocarpine for the
prevention of chemotherapy-induced oral mucositis in adult
patients with cancer. Eur J Cancer 37(16): 2010-2014, 2001.
101 Berger A, Henderson M, Nadoolman W, Duffy V, Cooper D,
Saberski L and Bartoshuk L: Oral capsaicin provides
temporary relief for oral mucositis pain secondary to
chemotherapy/radiation therapy. J Pain Symptom Manage
10(3): 243-248, 1995.
102 Yuki F, Kawaguchi T, Hazemoto K and Asou N: Preventive
effects of oren-gedoku-to on mucositis caused by anticancer
agents in patients with acute leukaemia. Gan To Kagaku
Ryoho 30(9): 1303-1307, 2003.
103 Seiter K, Kemeny N, Martin D, Schneider A, Williams L,
Colofiore J and Sawyer R: Uridine allows dose escalation of
5-fluorouracil when given with N-phosphonacetyl-L-aspartate,
methotrexate, and leucovorin. Cancer 71(5): 1875-1881, 1993.
104 Malik IA, Moid I, Haq S and Sabih M: A double-blind,
placebo-controlled, randomized trial to evaluate the role of
tetrachlorodecaoxide in the management of chemotherapyinduced
oral mucositis. J Pain Symptom Manage 14(2): 82-87,
1997.
105 Coetxee MJ, Boshoff B, Goedhals L and Pienaar FD: Formula
C-popular, cheep and readily available relief for radiation and
cancer chemotherapy mucositis. S Arf Med J 87(1): 80-81,
1997.
106 Feber T: Management of mucositis in oral irradiation. Clin
Oncol 8(2): 106-111, 1996.
1117